Search

Displaying results 5501 - 5510 of 6949 in total
  1. Drug

    Dabocemagene autoficel

    go.drugbank.com/drugs/DB17878
    Investigational

    Developed by Castle Creek Biosciences Inc., dabocemagene autoficel is being investigated for the treatment of dystrophic epidermolysis bullosa.[L46797]

  2. Drug

    Viralym-C

    go.drugbank.com/drugs/DB17975
    Investigational

    It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection.[A260291, L47241]

  3. Drug

    DYNE-251

    go.drugbank.com/drugs/DB18130
    Investigational

    It is being investigated for the treatment of Duchenne muscular dystrophy (DMD) in patients who are amenable to exon 51 skipping. … DYNE-251 is a phosphorodiamidate morpholino oligomer (PMO) conjugated to a fragment antibody (Fab) that binds to the transferrin receptor 1 (TfR1).

  4. Drug

    BO-653

    go.drugbank.com/drugs/DB19216
    Investigational

    BO-653 is under investigation in clinical trial NCT00055510 (A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and

  5. Drug

    Barbital

    go.drugbank.com/drugs/DB01483
    ExperimentalIllicit

    Barbital is also used in veterinary practice for central nervous system depression. Barbital is a schedule IV controlled drug.

  6. Drug

    Sibrotuzumab

    go.drugbank.com/drugs/DB06474
    Investigational

    Sibrotuzumab is a humanized monoclonal antibody directed against fibroblast activation protein (FAP). It is used to treat cancer.

  7. Drug

    Talastine

    go.drugbank.com/drugs/DB13349
    Experimental

    Categories: Antihistamines for Systemic Use
  8. Drug

    Nicofetamide

    go.drugbank.com/drugs/DB13531
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  9. Drug

    Dimethylaminopropionylphenothiazine

    go.drugbank.com/drugs/DB13672
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  10. Drug

    ACA 125

    go.drugbank.com/drugs/DB05489
    Investigational

    An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new conc...